CRNX

#1278
Crinetics Pharmaceuticals, Inc.
41.1000
-3.50%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
41.1000
41.1000
Годовой диапазон
38.8150
57.9900
Дневное изменение
-3.50%
Месячное изменение
-22.69%
6-месячное изменение
0.00%
Годовое изменение
0.00%
Предыдущее закрытие
42.5900
Open
41.1000
Bid
Ask
Low
41.1000
High
41.1000
Объем
130
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization 3.8722 B
  • Employee 437
  • Founded 2008
  • CEO N/A
  • Website www.crinetics.com
  • Headquarter Delaware, United States
  • FIGI BBG00BC59224
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.4
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.

Новости